Advancing transformative therapies for serious unmet medical needs in regenerative medicine and rare diseases.
Triovance develops innovative programs including TRV-01 for diabetic foot ulcers and PTT-621 for ROSAH syndrome.
.svg)
Advancing Transformative Therapies for Diabetic Foot Ulcers and ROSAH Syndrome
Triovance is advancing innovative therapeutic programs in regenerative medicine and rare disease, including TRV-01 for diabetic foot ulcers and PTT-621 for ROSAH syndrome.
.svg)
Meet the Team
Our mission is to develop transformative therapies for patients with rare and chronic-degenerative diseases — conditions where few or no treatment options exist — using innovative science based on tissue engineering, gene therapy, and cell therapy. Today that includes TRV-01 for diabetic foot ulcers and PTT-621 for ROSAH syndrome, a rare genetic disease.
News & articles
Stay up to date on our latest breakthroughs, product advancements, press releases and more.
Get in touch with our team of experts
If you have any questions or want to learn more about our solutions, feel free to reach out - we're here to help!
.svg)
